Autopsy report · NCT00720512
Second-Line Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer Who Have Received First-Line Chemotherapy and Bevacizumab
Cause of deathNo reason given
Life of this trial
- Registered 1 month after it had already started.
- Ran for about 5 years 9 months before it stopped.
- 184 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Gruppo Oncologico del Nord-Ovest
- Sponsor type
- University, hospital or other
- Conditions
- Colorectal Cancer
- Interventions
- bevacizumab; fluorouracil; irinotecan hydrochloride; leucovorin calcium; oxaliplatin
- Participants
- 184
- Sites
- 21
- Countries
- Italy
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.